粘菌素
鲍曼不动杆菌
抗菌剂
抗药性
多重耐药
病菌
重症监护医学
医学
病原生物
抗生素耐药性
微生物学
生物
抗生素
细菌
铜绿假单胞菌
遗传学
作者
Taison D. Bell,Stacy C. Park
出处
期刊:NEJM evidence
[Massachusetts Medical Society]
日期:2022-12-27
卷期号:2 (1)
被引量:3
摘要
Antimicrobial resistance (AMR) is an increasing global threat with estimates that drug-resistant infections contribute to nearly 5 million deaths worldwide every year.1 In particular, carbapenem-resistant Acinetobacter baumannii (CRAB) is emerging as a challenging pathogen to treat and has been designated by the World Health Organization as a priority pathogen for the development of new antimicrobial agents.2 Studies evaluating the efficacy of therapeutic strategies are vitally important in the fight against drug-resistant A. baumannii and other drug-resistant infections.
科研通智能强力驱动
Strongly Powered by AbleSci AI